FindTrial
Sign In

A study on determining utility of an internet based application used for dose adjustment in the chemotherapy medicines prescribed to the children diagnosed with acute lymphoblastic leukemia (a type of blood cancer).

Web based mobile application for titrating maintenance therapy in children with acute lymphoblastic leukemia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/096796
Enrollment
1000
Registered
2025-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C910- Acute lymphoblastic leukemia [ALL] Health Condition 2: C81- Hodgkin lymphoma Health Condition 3: C85- Other specified and unspecified types of non-Hodgkin lymphoma

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr. CHETAN DHAMNE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients with acute lymphoblastic leukemia/Lymphoma less than 15 years of age at the time of registration. 2. A parent/caretaker who understands the basic functioning of internet and committed enough to follow dose adjustment as communicated. 3. Written informed consent according to institutional guidelines.

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the study

Design outcomes

Primary

MeasureTime frame
To determine the feasibility of using a web-based application for monitoring maintenance therapy in patients with newly diagnosed acute lymphoblastic leukemia/lymphoma.Timepoint: The web application will be introduced to the patients after initiation of the maintenance therapy. The inputs and outputs from users are expected at 15 days interval.—

Secondary

MeasureTime frame
To assess the Health Related- Quality Of Life (HR-QOL) in children on maintenance therapyTimepoint: The web application will be introduced to the patients after initiation of the maintenance therapy.;To assess compliance to maintenance therapy in children with acute lymphoblastic leukemia/lymphoma.Timepoint: The web application will be introduced to the patients after initiation of the maintenance therapy. The inputs and outputs from users are expected at 15 days interval.;To assess adherence of medications during maintenance therapyTimepoint: The web application will be introduced to the patients after initiation of the maintenance therapy. The inputs and outputs from users are expected at 15 days interval.;Explore impact of dose intensity of maintenance therapyTimepoint: The web application will be introduced to the patients after initiation of the maintenance therapy. The inputs and outputs from users are expected at 15 days interval.;To study the social impact of maintenance therapy on patient and familiesTimepoint: The web application will be introduced to the patients after initiation of the maintenance therapy. The inputs and outputs from users are expected at 15 days interval.—

Countries

India

Contacts

Public ContactDr Shubham Kumar

Tata Memorial Hospital

chetandhamne@gmail.com9004300356

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026